identification of chronic heart failure patients with a high 12-month mortality risk using biomarkers including plasma C-terminal pro-endothelin-1

Ewa A. Jankowska, Gerasimos S. Filippatos, Stephan von Haehling, Jana Papassotiriou, Nils G. Morgenthaler, Mariantonietta Cicoira, Joerg C. Schefold, Piotr Rozentryt, Beata Ponikowska, Wolfram Doehner, Waldemar Banasiak, Oliver Hartmann, Joachim Struck, Andreas Bergmann, Stefan D. Anker, Piotr Ponikowski

Research output: Contribution to journalArticle

Abstract

Objectives: We hypothesised that assessment of plasma C-terminal pro-endothelin-1 (CT-proET-1), a stable endothelin-1 precursor fragment, is of prognostic value in patients with chronic heart failure (CHF), beyond other prognosticators, including N-terminal pro-B-type natriuretic peptide (NT-proBNP). Methods: We examined 491 patients with systolic CHF (age: 63±11 years, 91%men, New York Heart Association [NYHA] class [I/ II/III/IV]: 9%/45%/38%/8%, 69% ischemic etiology). Plasma CT-proET-1 was detected using a chemiluminescence immunoassay. Results: Increasing CT-proET-1 was a predictor of increased cardiovascular mortality at 12-months of follow-up (standardized hazard ratio 1.42, 95% confidence interval [CI] 1.04-1.95, p = 0.03) after adjusting for NT-proBNP, left ventricular ejection fraction (LVEF), age, creatinine, NYHA class. In receiver operating characteristic curve analysis, areas under curve for 12-month follow-up were similar for CT-proET-1 and NT-proBNP (p = 0.40). Both NT-proBNP and CT-proET-1 added prognostic value to a base model that included LVEF, age, creatinine, and NYHA class. Adding CT-proET-1 to the base model had stronger prognostic power (p

Original languageEnglish
Article numbere14506
JournalPLoS One
Volume6
Issue number1
DOIs
Publication statusPublished - 2011

ASJC Scopus subject areas

  • Agricultural and Biological Sciences(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Fingerprint Dive into the research topics of 'identification of chronic heart failure patients with a high 12-month mortality risk using biomarkers including plasma C-terminal pro-endothelin-1'. Together they form a unique fingerprint.

  • Cite this

    Jankowska, E. A., Filippatos, G. S., von Haehling, S., Papassotiriou, J., Morgenthaler, N. G., Cicoira, M., Schefold, J. C., Rozentryt, P., Ponikowska, B., Doehner, W., Banasiak, W., Hartmann, O., Struck, J., Bergmann, A., Anker, S. D., & Ponikowski, P. (2011). identification of chronic heart failure patients with a high 12-month mortality risk using biomarkers including plasma C-terminal pro-endothelin-1. PLoS One, 6(1), [e14506]. https://doi.org/10.1371/journal.pone.0014506